Antibiotice Ia (ATB) — Cash Flow Quality Index
Antibiotice Ia (ATB) has a Cash Flow Quality Index of 4.12x as of December 2025. Operating cash flow of RON37.61 Million exceeds net income of RON9.13 Million, indicating high earnings quality where cash backs reported profits. Also explore Antibiotice Ia balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Antibiotice Ia Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Antibiotice Ia across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ATB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Antibiotice Ia (2022–2025)
Year-by-year earnings quality comparison for Antibiotice Ia. For live market cap and the full company financial profile, see ATB stock market capitalisation.
| Year | Quality Index | Operating CF (RON) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.40x | RON72.44 Million | RON51.77 Million | ▲ +50.3% |
| 2024 | 0.93x | RON95.15 Million | RON102.20 Million | ▼ -38.4% |
| 2023 | 1.51x | RON122.46 Million | RON81.09 Million | ▼ -49.7% |
| 2022 | 3.00x | RON115.66 Million | RON38.51 Million | — |